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Learning Point for Clinicians
Classically, takotsubo cardiomyopathy (TTC) or
‘broken-heart-syndrome’, describes the associ-
ation of a trigger factor such as ‘death of a
loved one’ with induction of a transient cardio-
myopathy. However, the trigger factor can be any
one of a diverse group of physical or emotional
stressors. It has recently been reported that drug
withdrawl, particularly from opiates, can also
initiate TTC. Thus, prompt recognition of with-
drawal-associated TTC is essential for appropriate
management and optimal clinical outcome.
Case report
A 60-year-old woman with hepatitis C, major de-
pression and chronic pain syndrome presented to
the emergency department complaining of abdom-
inal discomfort, chills, diaphoresis, nausea and
emesis for 72 hr. Several days prior to presentation,
she had run out of MS Contin 100mg (qid), and
because of her symptoms she had discontinued all
her medications for 48 hr. Her cardiovascular risk
factors were cigarette smoking and hypertension.
On admission, the patient was in distress, reiter-
ating her need for morphine. Vital signs were blood
pressure 141/89mm Hg, pulse 117/min and
respiratory rate 24/min. Her chemistry panel and
venous blood gases revealed a mixed acid base dis-
order and liver function tests were normal. Shortly
after she complained of sudden onset of chest pain
and her electrocardiogram showed ST-segment ele-
vation in the precordial leads. Troponin I was ele-
vated (21.12 ng/ml, ref <0.04). Echocardiography
revealed left ventricular (LV) ejection fraction of
35% with apical akinesis and hypokinesis of the
mid-anterior and mid-inferior segments (Figure 1).
The patient received urgent cardiac catheterization,
which revealed no significant coronary artery dis-
ease. Left ventriculography demonstrated LV apical
akinesis, basal hypercontractility, and LV ejection
fraction of 40%, and LV end diastolic pressure of
29mm Hg. These findings were consistent with
takotsubo cardiomyopathy (TTC) and the patient
was transferred to the cardiac care unit where a
nitroprusside infusion was initiated and morphine
was administered. The patient’s hospital course
was complicated by pulmonary edema, which
required intensive therapy including diuresis, vaso-
dilators and brief ventilatory support. Over the next
several days, therapy with an angiotensin converting
enzyme inhibitor and beta-blocker was started.
Morphine was progressively decreased and discon-
tinued after <1 week. The patient’s condition stabi-
lized over the next 3 weeks. By hospital day 27, she
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was fully ambulatory, her echocardiogram had nor-
malized, and her electrocardiogram had only re-
sidual anterior T-wave inversion.
Discussion
TTC is characterized by transient, regional systolic
dysfunction of the left ventricle without obstructive
epicardial coronary artery disease. It predominantly
affects postmenopausal women and is frequently
triggered by an emotional or a physical stressor.1
TTC related to medication withdrawal has been re-
ported in a diverse group of patients. Interestingly,
Americans account for approximately 80% of the
global consumption of prescription analgesics.2
The rising consumption of analgesic medications
worldwide suggests a potential increase in the fre-
quency of withdrawal-associated TTC.
The pathophysiology of TTC is not well under-
stood, but excessive catecholamine and adrenergic
stimulation have been implicated.3 Drug withdrawal
can be associated with a hyperadrenergic state and
central nervous system irritability,4 which may pro-
vide a mechanism for withdrawal-associated TTC.
We have identified seven additional cases of drug
withdrawal-associated TTC in our International
Takotsubo Registry at the leading hospital Zurich,
Switzerland (www.takotsubo-registry.com). We sug-
gest that withdrawal-associated TTC is under-diag-
nosed due to limited awareness. The majority of
these patients was women with ST-segment eleva-
tion and all demonstrated the LV apical ballooning
pattern, with reduced ejection fraction of 36%. In-
hospital complications occurred among our patients
including one death. Our patient’s complex presen-
tation involving opiate withdrawal and TTC was
manifested by acute pulmonary edema and meta-
bolic alkalosis, which prolonged her hospitalization.
Recognition of the potential for patients to develope
TTC during drug withdrawal to develop TTC is es-
sential for appropriate management and favorable
outcome.
Conflict of interest: None declared.
References
1. Merchant EE, Johnson SW, Nguyen P, Kang C, Mallon WK.
Takotsubo cardiomyopathy: a case series and review of the
literature. West J Emerg Med 2008; 9:104–411.
2. Manchikanti L, Fellows B, Ailinani H, Pampati V.
Therapeutic use, abuse, and nonmedical use of opioids: a
ten-year perspective. Pain Physician 2010; 13:401–35.
3. Wittstein IS, Thiemann DR, Lima JA, Baughman KL,
Schulman SP, Gerstenblith G, et al. Neurohumoral features
of myocardial stunning due to sudden emotional stress. N
Engl J Med 352:539–48.
4. McDonald T, Hoffman WE, Berkowitz R, Cunningham F,
Cooke B. Heart rate variability and plasma catecholamines
in patients during opioid detoxification. J Neurosurg
Anesthesiol 1999; 11:195–9.
Figure 1. Echocardiography reveals left ventricular ejection fraction of 35% with apical ballooning pattern (A in systole and
B in diastole).
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